Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pathway Pharmaceuticals is a Hong Kong-based personalized medicine and bioinformatics company founded in 2014. The company developed its flagship platform, OncoFinder, a proprietary biomathematical algorithm designed to analyze intracellular signaling pathway activation using transcriptomic data. OncoFinder was utilized to predict the efficacy of targeted cancer therapies and personalize treatment plans for individual oncology patients. Pathway Pharmaceuticals established notable collaborations, including a partnership with IBM Watson Health in 2015 to integrate its pathway analysis with cognitive computing, and an exclusive licensing agreement with Insilico Medicine. The company is currently inactive (deadpooled).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pathway Pharma.